Citation Impact
Citing Papers
Circadian oscillation of nucleotide excision repair in mammalian brain
2009 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
1994
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial
2000
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group
1996
A view on drug resistance in cancer
2019 StandoutNature
Breast cancer
2016 Standout
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
2010
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
2004
Cisplatin resistance in human cancers
1991
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Ovarian cancer
2014 Standout
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study
2005
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
2012
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers
1995
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Oxaliplatin (L-OHP): a new reality in colorectal cancer
1998
Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein
2010 StandoutNobel
Plasticity of disseminating cancer cells in patients with epithelial malignancies
2012
New Cisplatin Analogues in Development
1993
Tumor metastasis: moving new biological insights into the clinic
2013
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
Colorectal cancer
2019 Standout
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
1999
Ovarian function and childbearing issues in breast cancer survivors
2007
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Target cell movement in tumor and cardiovascular diseases based on the epithelial–mesenchymal transition concept
2011
Oesophageal carcinoma
2013 Standout
Type 2 diabetes
2017 Standout
Robust enumeration of cell subsets from tissue expression profiles
2015 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Role of bisphosphonates in postmenopausal women with breast cancer
2013
Cancer micrometastases
2009
Emerging Biological Principles of Metastasis
2017 Standout
Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof onIn VivoProperties
2013
EMT: 2016
2016 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
1998
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer
2007
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer
2014
Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.
1998
A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma
2012
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions
2007
Treatment of Breast Cancer
1998
Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients
2007
Metastatic colonization by circulating tumour cells
2016 StandoutNature
New platinum antitumor complexes
1993
Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer
2008
Preservation of Fertility in Patients with Cancer
2009 Standout
Anemia of Chronic Disease
2005 Standout
Oxaliplatin in practice
1998
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
2013
Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: Crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2]
1998
GEL ENTRAPMENT AND MICRO-ENCAPSULATION: METHODS, APPLICATIONS AND ENGINEERING PRINCIPLES
1996
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal Cancer
2002
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Chemical Routes for the Transformation of Biomass into Chemicals
2007 Standout
Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal
1996
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Synthesis and Characterization of Novel Axial Dichloroplatinum(IV) Cisplatin Analogues: Crystal Structure of an Axial Dichloro Complex [Pt(cis-1,4-DACH)(trans-Cl2)(CBDCA)]·1/2MeOH
1997
Current status of trans-platinum compounds in cancer therapy
2001
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Additions to Metal-Activated Organonitriles
2002 Standout
Breast Cancer Treatment
2019 Standout
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
Circadian Rhythms: Mechanisms and Therapeutic Implications
2007
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
2000
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Colloidosomes: Selectively Permeable Capsules Composed of Colloidal Particles
2002 StandoutScience
MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples
2013
Metabolic reprogramming and cancer progression
2020 StandoutScience
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
2014
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Biotechnological production of xylitol. Part 1: Interest of xylitol and fundamentals of its biosynthesis
1998
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Chemical and Biological Studies on a Series of Novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-Diaminocyclohexane)platinum(IV) Carboxylate Complexes
1997
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
1997
The current status of new platinum analogs.
1992
Works of L. Mignot being referenced
A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer
2010
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
2008
After Cystectomy, Is It Justified to Perform a Bladder Replacement for Patients with Lymph Node Positive Bladder Cancer?
2002
Phase I study of oxaliplatin in patients with advanced cancer
1990
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma
1998
Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?
2008
Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer
2009
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience
2010
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
2011
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.
1996
Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.
1995
Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
2008
Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study
2013
Influence of the oxygenation level on d-xylose fermentation by free and agar-entrapped cultures of Candida shehatae
1995
Diffusion in immobilized-cell agar layers: influence of microbial burden and cell morphology on the diffusion coefficients ofl-malic acid and glucose
1990
[Pregnancy after treated breast cancer. Results of a case-control study].
1986